Cancer

INDICATION: Brain cancer; prostate cancer

Cell culture and mouse studies suggest Bcl-XL inhibitors could help treat glioma, prostate and other cancers harboring the IDH1 R123H mutation. In human glioma and prostate cancer cell

Read the full 320 word article

User Sign In